How do you propel science forward in between discoveries? Or when the lab is closed? How about when researchers are remote?

You become your own research publishing platform.

This accomplishes three things:

1. It makes your people, programs and projects more visible

Harvard is a great example. Ten years ago, they built websites department by department. Departments used different software, agencies, processes, and budgets to achieve their goals. The result was thousands of disconnected websites with different branding, missing research, and dollars wasted.

Harvard wanted a more efficient, unified approach. Unsatisfied with the options available, they created an open publishing platform that allowed every researcher, department, and team to tell their unique stories. Anyone at Harvard, from graduate student to tenured faculty to labs to departments to special projects, can create a website with a click of a button. On it, they publish important research, publications, stories, and collaborations. Researchers take pride in sharing their work publicly while feeling in control of their content.

This inclusive

Findable is Fundable. This is an idea that most researchers agree with. To increase your likelihood of attracting funding and collaborators, you need to have a web presence where you tell your unique story. You support that story with data and details - about your latest research insights, your publications and your all-star team.

This is more important than ever as growth in science requires growth in funding, which has remained relatively flat for a long time, but has declined as a percent of the federal budget and for many projects not related to Covid-19 is restricted or paused.

While the NIH is the largest public funder of biomedical research in the world, competition remains high. So you want to stack the deck so that the foundation or the private donor or the pharmaceutical company who doesn't know you today, finds you and reaches out.

It’s matchmaking stories like this one that we love hearing: A Texas Tycoon Throws Millions at the Covid-19 Testing Puzzle

But